Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 6:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 6,918 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Comatose
Interventions: Transcutaneous electrical stimulation, Standard of Care (SOC); Device · Other
Lead sponsor: Markey Olson; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Spinal Cord Injuries, Blood Pressure Disorders
Interventions: ARC-IM System Implantation, ARC-IM Therapy (Group 1), ARC-IM Therapy (Group 2); Procedure · Device
Lead sponsor: ONWARD Medical, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 12
States / cities: Little Rock, Arkansas • Englewood, Colorado • Miami, Florida + 8 more

Conditions: Total Knee Arthroplasty (Postoperative Pain), Total Hip Arthroplasty (Postoperative Pain)
Interventions: Transcranial Direct Current Stimulation, Cognitive-Behavioral (CB) intervention; Device · Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 90 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Breast Cancer
Interventions: filgrastim, pegfilgrastim, cediranib maleate, cyclophosphamide, docetaxel, doxorubicin hydrochloride, laboratory biomarker analysis, conventional surgery, neoadjuvant therapy; Biological · Drug · Other + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 2
States / cities: Bethesda, Maryland • New Brunswick, New Jersey

Conditions: Stroke
Interventions: high frequency rTMS; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Depressive Disorder, Major, Unipolar Depression
Interventions: Deep Brain Stimulation, Libra Deep Brain Stimulation System; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 21 Years to 70 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 11
States / cities: Stanford, California • Chicago, Illinois • Worcester, Massachusetts + 8 more

Conditions: Pain, Back Pain, Lower Back Pain, Quality of Life
Interventions: Dry Needling, Dry needling with high-rate PENS, Dry needling with low-rate PENS; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 65 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Cervical Dystonia, Spasmodic Torticollis
Interventions: rTMS; Device
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 100 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Mild Cognitive Impairment (MCI)
Interventions: AI-Supported Cognitive Rehabilitation; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 65 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Anhedonia
Interventions: active tDCS, sham tDCS; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke
Interventions: radio frequency-controlled (RF) Microstimulator (RFM) Gait System; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Leukemia
Interventions: filgrastim, recombinant interferon alfa, busulfan, cytarabine, etoposide, hydroxyurea, idarubicin, peripheral blood stem cell transplantation; Biological · Drug · Procedure
Lead sponsor: Eastern Cooperative Oncology Group; Network
Eligibility: 15 Years to 65 Years
Enrollment: 744 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1997
U.S. locations: 2
States / cities: Hackensack, New Jersey • Red Bank, New Jersey

Conditions: Stroke
Interventions: Repetitive Peripheral Magnetic Stimulation (rPMS), Sham Priming; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Parkinson Disease
Interventions: aDBS; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: ADHD
Interventions: intermittent theta burst stimulation (iTBS); Device
Lead sponsor: Bradley Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: East Providence, Rhode Island

Conditions: Post-ect Agitation, Post-ictal Agitation
Interventions: Weighted blanket, Usual Care Group; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Sleep Apnea Syndromes
Interventions: Transvenous nerve stimulation; Device
Lead sponsor: Respicardia, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Winston-Salem, North Carolina • Columbus, Ohio • Bryn Mawr, Pennsylvania

Conditions: Hemiparesis
Interventions: tDCS; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 8 Years to 17 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cerebellar Ataxia, Cerebellar Diseases, Cerebellar Stroke, Cerebellar Tumor
Interventions: Therapy; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cognition, Brain Health, Brain Structure, Brain Function
Interventions: Digital Program 1, Digital Program 2; Device
Lead sponsor: Lumos Labs, Inc.; Industry
Eligibility: 25 Years to 80 Years
Enrollment: 817 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Spinal Cord Injuries, Spinal Cord Diseases, Paralysis, Central Nervous System Diseases, Cough, Trauma, Nervous System, Wounds and Injuries
Interventions: Spinal Cord Stimulation to restore cough, Expiratory Muscle Stimulator; Procedure · Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Breast Cancer
Interventions: GP2 peptide + GM-CSF vaccine, GM-CSF (sargramostim), AE37 + GM-CSF vaccine; Biological
Lead sponsor: San Antonio Military Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 456 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 11
States / cities: Washington D.C., District of Columbia • Honolulu, Hawaii • Baltimore, Maryland + 7 more

Conditions: Moyamoya Syndrome, Moyamoya Disease, Atheroscleroses, Cerebral
Interventions: Soterix® 4x1HD-TDCS, Soterix® 1x1 tDCS, Cognitive training program; Device · Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Spinal Cord Injury, Urinary Incontinence
Interventions: Vibrator, Anal dilator; Device · Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Hines, Illinois

Search by objective public record fields.

A Study of Transcutaneous Electrical Stimulation As a Noxious Stimulus for the Glasgow Coma Scale

ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury

Effects of tDCS Combined With CBI on Postsurgical Pain

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Non-invasive Brain Stimulation (NIBS) and Dual-task Walking After Stroke

Deep Brain Stimulation for Major Depressive Disorder

Pain Intervention With Needling: Pilot Of Integrated Neuromodulation Techniques

Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study

AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment

Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression

Enhancing Function Using the RF Microstimulator Gait System Following Stroke 2008

Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

The Effect of rPMS on Motor Skill Performance in Persons With a Stroke.

Adaptive DBS to Offset STN Dysregulation During Exercise in PD

Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD

Peri-procedural Weighted Blanket Use for ECT

Janus Feasibility Study

Safety of Transcranial Direct Current Stimulation in Pediatric Hemiparesis

Individualized Neuro-Modulation Paired With Cerebellar Therapy

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

Spinal Cord Stimulation to Restore Cough

Vaccine Therapy in Treating Patients With Breast Cancer

A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfusion

Two Devices for Reflex Voiding Following Spinal Cord Injury